C R Bard (BCR)
C.R. Bard, Inc. designs, develops, manufactures, distributes and markets medical technologies in the fields of vascular, urology, oncology and surgical specialty products. It sells a range of products to hospitals, individual healthcare professionals, extended care facilities and alternate site facilities. The company was founded by Charles Russell Bard in 1907 and is headquartered in Murray Hill, NJ.
|Market Price at 20-10-2017||$330.16|
|Price to Earnings Ratio||21.83|
|Market Capitalisation||$23,993.39 (million)|
|Return on Equity (ROE)||46.19%|